Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 8Thoracic 3Gastrointestinal 3Sarcoma 2Head & Neck 2Genitourinary 2Gynecologic 1Dermatologic 1Breast 1

Conditions

Carcinoma, Hepatocellular 29Stomach Neoplasms 13Esophageal Neoplasms 13Colorectal Neoplasms 12Esophageal Squamous Cell Carcinoma 10Rectal Neoplasms 7Pancreatic Neoplasms 7Biliary Tract Neoplasms 7Head and Neck Neoplasms 5Colonic Neoplasms 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Locally Advanced Rectal Cancer 4Liver Neoplasms 4Ovarian Neoplasms 3Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Anus Neoplasms 3Turcot syndrome 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pathologic Complete Response 2Gastric / Gastroesophageal Junction Adenocarcinoma 2Digestive System Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Spinocerebellar Degenerations 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Immune Checkpoint Inhibitors × Gastrointestinal × Clear all
NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

DEKA Biosciences

Phase 1 Active not recruiting
39 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT05716295 2024-05-08

ORCHID-1

Medikine, Inc.

Phase 1/2 Terminated
26 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05322187 2022-04-11

sPLENTY-pc

RenJi Hospital

Phase 2/3 Unknown
15 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡